LASN01, Sodium Chloride 0.9% Intravenous Infusion BP, Water for Injections BP. clinical trials

A Phase 2, Proof-of-Concept, Randomized, Double-Masked, Placebo-Controlled Study to Determine the Efficacy and Safety of LASN01 in Patients with Thyroid Eye Disease

This study is testing a new medicine called LASN01 for people with an eye condition called Thyroid Eye Disease. Researchers want to see if LASN01 can help improve eye bulging and if it's safe to use. It's a key step to understand if this new treatment could work.